JP2022502056A5 - - Google Patents
Info
- Publication number
- JP2022502056A5 JP2022502056A5 JP2021517352A JP2021517352A JP2022502056A5 JP 2022502056 A5 JP2022502056 A5 JP 2022502056A5 JP 2021517352 A JP2021517352 A JP 2021517352A JP 2021517352 A JP2021517352 A JP 2021517352A JP 2022502056 A5 JP2022502056 A5 JP 2022502056A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- amino acid
- seq
- exon
- variable domain
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811123747.0A CN110950949B (zh) | 2018-09-26 | 2018-09-26 | 一种识别ssx2抗原的t细胞受体 |
| CN201811123747.0 | 2018-09-26 | ||
| PCT/CN2019/107097 WO2020063488A1 (zh) | 2018-09-26 | 2019-09-20 | 一种识别ssx2抗原的t细胞受体 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022502056A JP2022502056A (ja) | 2022-01-11 |
| JPWO2020063488A5 JPWO2020063488A5 (https=) | 2022-09-29 |
| JP2022502056A5 true JP2022502056A5 (https=) | 2022-09-29 |
| JP7452880B2 JP7452880B2 (ja) | 2024-03-19 |
Family
ID=69949278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021517352A Active JP7452880B2 (ja) | 2018-09-26 | 2019-09-20 | Ｓｓｘ２抗原を識別するｔ細胞受容体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11649270B2 (https=) |
| EP (1) | EP3858852B1 (https=) |
| JP (1) | JP7452880B2 (https=) |
| CN (1) | CN110950949B (https=) |
| CA (1) | CA3114451A1 (https=) |
| WO (1) | WO2020063488A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20210687A (es) | 2019-06-25 | 2022-03-03 | Gilead Sciences Inc | PROTEÍNAS DE FUSIÓN FLT3L-Fc Y MÉTODOS DE USO |
| CN112442119B (zh) * | 2019-09-05 | 2023-02-24 | 香雪生命科学技术（广东）有限公司 | 一种识别ssx2的高亲和力t细胞受体 |
| KR20260017503A (ko) | 2020-02-14 | 2026-02-05 | 길리애드 사이언시즈, 인코포레이티드 | Ccr8에 결합하는 항체 및 융합 단백질, 및 이의 용도 |
| TWI815194B (zh) | 2020-10-22 | 2023-09-11 | 美商基利科學股份有限公司 | 介白素2-Fc融合蛋白及使用方法 |
| CN114524870A (zh) * | 2020-11-23 | 2022-05-24 | 香雪生命科学技术（广东）有限公司 | 源自于ssx2抗原的短肽 |
| TW202313094A (zh) | 2021-05-18 | 2023-04-01 | 美商基利科學股份有限公司 | 使用ＦＬＴ３Ｌ—Ｆｃ融合蛋白之方法 |
| US20230183216A1 (en) | 2021-10-28 | 2023-06-15 | Gilead Sciences, Inc. | Pyridizin-3(2h)-one derivatives |
| EP4422756A1 (en) | 2021-10-29 | 2024-09-04 | Gilead Sciences, Inc. | Cd73 compounds |
| EP4452415B1 (en) | 2021-12-22 | 2026-02-25 | Gilead Sciences, Inc. | Ikaros zinc finger family degraders and uses thereof |
| CN118488946A (zh) | 2021-12-22 | 2024-08-13 | 吉利德科学公司 | Ikaros锌指家族降解剂及其用途 |
| TW202340168A (zh) | 2022-01-28 | 2023-10-16 | 美商基利科學股份有限公司 | Ｐａｒｐ７抑制劑 |
| CA3253296A1 (en) | 2022-03-17 | 2023-09-21 | Gilead Sciences, Inc. | Zinc Finger Degradation Agents of the Ikaros Family and Their Uses |
| WO2023205719A1 (en) | 2022-04-21 | 2023-10-26 | Gilead Sciences, Inc. | Kras g12d modulating compounds |
| US20240116928A1 (en) | 2022-07-01 | 2024-04-11 | Gilead Sciences, Inc. | Cd73 compounds |
| EP4638436A1 (en) | 2022-12-22 | 2025-10-29 | Gilead Sciences, Inc. | Prmt5 inhibitors and uses thereof |
| CN120882725A (zh) | 2023-04-11 | 2025-10-31 | 吉利德科学公司 | Kras调节化合物 |
| WO2024220917A1 (en) | 2023-04-21 | 2024-10-24 | Gilead Sciences, Inc. | Prmt5 inhibitors and uses thereof |
| US20250042922A1 (en) | 2023-06-30 | 2025-02-06 | Gilead Sciences, Inc. | Kras modulating compounds |
| AU2024297978A1 (en) | 2023-07-26 | 2026-02-05 | Gilead Sciences, Inc. | Parp7 inhibitors |
| US20250066328A1 (en) | 2023-07-26 | 2025-02-27 | Gilead Sciences, Inc. | Parp7 inhibitors |
| WO2025054347A1 (en) | 2023-09-08 | 2025-03-13 | Gilead Sciences, Inc. | Kras g12d modulating compounds |
| AU2024337913A1 (en) | 2023-09-08 | 2026-03-26 | Gilead Sciences, Inc. | Pyrimidine-containing polycyclic derivatives as kras g12d modulating compounds |
| US20250154172A1 (en) | 2023-11-03 | 2025-05-15 | Gilead Sciences, Inc. | Prmt5 inhibitors and uses thereof |
| WO2025137640A1 (en) | 2023-12-22 | 2025-06-26 | Gilead Sciences, Inc. | Azaspiro wrn inhibitors |
| US20250376484A1 (en) | 2024-05-21 | 2025-12-11 | Gilead Sciences, Inc. | Prmt5 inhibitors and uses thereof |
| WO2026039365A1 (en) | 2024-08-12 | 2026-02-19 | Gilead Sciences, Inc. | Kras modulating compounds |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6287756B1 (en) * | 1997-05-05 | 2001-09-11 | Ludwig Institute For Cancer Research | Methods for determining presence of cancer in a sample by determining expression of an SSX gene |
| WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
| US8637305B2 (en) * | 2001-11-07 | 2014-01-28 | Mannkind Corporation | Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| WO2004022709A2 (en) * | 2002-09-06 | 2004-03-18 | Mannkind Corporation | Epitope sequences |
| NZ564359A (en) | 2005-06-17 | 2011-09-30 | Mannkind Corp | Analogs of pepetides corresponding to class I MHC-restricted T cell epitopes |
| CN103124740B (zh) * | 2010-09-21 | 2015-09-02 | 美国卫生和人力服务部 | 抗-ssx-2t细胞受体和相关材料及使用方法 |
| CN102173056B (zh) * | 2010-12-30 | 2014-09-03 | 联塑(杭州)机械有限公司 | 形成发泡产品的方法及其系统 |
| RU2645256C2 (ru) * | 2013-06-26 | 2018-02-19 | Гуандун Сянсюэ Лайф Сайенсис, Лтд. | Высокостабильный т-клеточный рецептор и способ его получения и применения |
| GB201313377D0 (en) * | 2013-07-26 | 2013-09-11 | Adaptimmune Ltd | T cell receptors |
| JP6777841B2 (ja) * | 2015-10-23 | 2020-10-28 | 国立大学法人金沢大学 | 細胞傷害性ｔ細胞の作製方法 |
| CN106519019B (zh) * | 2015-11-06 | 2018-07-03 | 广东香雪精准医疗技术有限公司 | 识别prame抗原的tcr |
| CN108117596B (zh) * | 2016-11-29 | 2023-08-29 | 香雪生命科学技术（广东）有限公司 | 针对ny-eso的高亲和力tcr |
| US20210061914A1 (en) * | 2017-12-28 | 2021-03-04 | Gritstone Oncology, Inc. | Antigen-Binding Proteins Targeting Shared Antigens |
| CN110343167B (zh) * | 2018-04-03 | 2022-10-28 | 香雪生命科学技术（广东）有限公司 | 识别ssx2抗原短肽的t细胞受体 |
| CN113795586B (zh) * | 2019-03-25 | 2026-03-27 | 大学健康网络 | T细胞受体及其使用方法 |
-
2018
- 2018-09-26 CN CN201811123747.0A patent/CN110950949B/zh active Active
-
2019
- 2019-09-20 WO PCT/CN2019/107097 patent/WO2020063488A1/zh not_active Ceased
- 2019-09-20 US US17/279,372 patent/US11649270B2/en active Active
- 2019-09-20 JP JP2021517352A patent/JP7452880B2/ja active Active
- 2019-09-20 EP EP19864082.3A patent/EP3858852B1/en active Active
- 2019-09-20 CA CA3114451A patent/CA3114451A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022502056A5 (https=) | ||
| JP2021531834A5 (https=) | ||
| JPWO2020063488A5 (https=) | ||
| HRP20230542T1 (hr) | T stanični receptori | |
| JP2021520198A5 (https=) | ||
| RU2016101711A (ru) | Высокостабильный т-клеточный рецептор и способ его получения и применения | |
| HRP20220865T1 (hr) | T stanični receptori | |
| JP2022115876A5 (https=) | ||
| JP2023139070A5 (https=) | ||
| US6416971B1 (en) | Soluble single chain T cell receptors | |
| JP2020501550A5 (https=) | ||
| JP2018504092A5 (https=) | ||
| HRP20221021T1 (hr) | T stanični receptori specifični za kompleks tumorskog antigena ny-eso-1 sa hla-a*02 | |
| IL308851B1 (en) | T cell modulatory multimeric polypeptides and methods of using them | |
| JPH06502997A (ja) | ヒトＴリンパ球レセプターのβ鎖の可変領域をコードするヌクレオチド配列対応するペプチドセグメント並びに診断及び治療への利用 | |
| JPWO2019195486A5 (https=) | ||
| CN113195530B (zh) | 抗体融合蛋白、制备方法及其应用 | |
| RU2014135053A (ru) | Иммуногены для вакцинации против вич | |
| JP2018522061A5 (https=) | ||
| CN106336457B (zh) | 识别mage‑a3抗原短肽的t细胞受体 | |
| CN106478808B (zh) | 识别ny-eso-1抗原短肽的t细胞受体 | |
| CN106632658B (zh) | 识别ny-eso-1抗原短肽的tcr | |
| JP2022502078A5 (https=) | ||
| KR20220012227A (ko) | Clec9a-기반 키메라 단백질 복합체 | |
| JPWO2020024915A5 (https=) |